Want to join the conversation?
Biotechnology company $CELG reported a rise in 2Q16 earnings driven by higher product sales. Net income rose to $598.2MM or $0.75 per share from $356.2MM or $0.43 per share last year. Total revenue grew to $2.75Bil from $2.28Bil. Adjusted EPS increased to $1.44 from $1.23.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.